← All trials
NCT00198263
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2004
- Primary completion
- Sep 30, 2008
- Completion date
- Sep 30, 2008
- First posted
- Sep 20, 2005
- Last posted
- Oct 3, 2017
- Enrollment
- 95
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Inovio PharmaceuticalsLead sponsor
- Inovio PharmaceuticalsStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.